Link Details
- Metabolite
- HMDB0000122 (D-Glucose)
- DrugBank ID
- DB00335
- Drug Name
- Atenolol
- Effect
- Increase
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Wikoff WR, Frye RF, Zhu H, Gong Y, Boyle S, Churchill E, Cooper-Dehoff RM, Beitelshees AL, Chapman AB, Fiehn O, Johnson JA, Kaddurah-Daouk R: Pharmacometabolomics reveals racial differences in response to atenolol treatment. PLoS One. 2013;8(3):e57639. doi: 10.1371/journal.pone.0057639. Epub 2013 Mar 11. [PubMed:23536766 ]
- Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F: Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann Intern Med. 1997 Jun 15;126(12):955-9. [PubMed:9182472 ]
- Pelttari L, Rauhala E, Kantola I: Effects of antihypertensive medication on hypertension in patients with sleep apnoea. Blood Press Suppl. 1994;2:88-91. [PubMed:8061854 ]
- Peden NR, Dow RJ, Isles TE, Martin BT, Yee KF, Buchanan KD: The effect of chronic treatment with a non-selective beta-adrenoceptor antagonist on the enteroinsular axis and intermediary metabolites. Diabetes Res. 1985 May;2(3):135-9. [PubMed:3905182 ]
- Wheeldon NM, McDevitt DG, Lipworth BJ: Do beta 3-adrenoceptors mediate metabolic responses to isoprenaline. Q J Med. 1993 Sep;86(9):595-600. [PubMed:8255974 ]